Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease

被引：0
|
作者：
Theodoraki, E. [1 ]
Orfanoudaki, E. [2 ]
Foteinogiannopoulou, K. [2 ]
Koutroubakis, I. [2 ]
机构：
[1] Univ Hosp Heraklion, Dept Gastroenterol, Iraklion, Greece
[2] Univ Hosp Heraklion, Sch Med, Dept Gastroenterol, Iraklion, Greece
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P505
引用
收藏
页码：I466 / I466
页数：1
相关论文
共 50 条
  • [21] Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease
    Greener, Tomer
    Kabakchiev, Boyko
    Steinhart, A. Hillary
    Silverberg, Mark S.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (08) : 1808 - 1814
  • [22] BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE
    Sanchez Yanez, E.
    Fuentes Ibanez, M. B.
    Mora Santiago, R.
    ATENCION FARMACEUTICA, 2008, 10 (04): : 234 - 240
  • [23] Biological therapy of inflammatory bowel disease
    Owczarek, Danuta
    Cibor, Dorota
    Szczepanek, Malgorzata
    Mach, Tomasz
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (1-2): : 84 - 88
  • [24] Infliximab in inflammatory bowel disease: attention to adverse events
    Uyanikoglu, A.
    Ermis, F.
    Akyuz, F.
    Pinarbasi, B.
    Baran, B.
    Aydogan, T.
    Demir, K.
    Besisik, F.
    Kaymakoglu, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (16) : 2337 - 2342
  • [25] Optimizing the use of biological therapy in patients with inflammatory bowel disease
    Moss, Alan C.
    GASTROENTEROLOGY REPORT, 2015, 3 (01): : 63 - 68
  • [26] Adverse events leading to modification of therapy in a large cohort of azathioprine-treated patients with inflammatory bowel disease
    Hindorf, Ulf
    Lindqvist, Malin
    Hildebrand, Hans
    Fagerberg, Ulrika
    Almer, Sven
    GASTROENTEROLOGY, 2006, 130 (04) : A619 - A619
  • [27] Co-prescription of allopurinol can overcome adverse events of thiopurine therapy in inflammatory bowel disease patients
    Beswick, L.
    Friedman, A. B.
    Jakobovits, S. L.
    Headon, B.
    Gibson, P. R.
    Sparrow, M. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 98 - 98
  • [28] Immunomodulator and biological therapy are increased in inflammatory bowel disease patients with associated immune-mediated inflammatory diseases
    Garcia Garcia, M. J.
    Pascual Mato, M.
    Del Pozo Calzada, C.
    Rasines Perez, L.
    Castro Senosiain, B.
    Crespo Garcia, J.
    Rivero Tirado, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S245 - S246
  • [29] ADVERSE EVENTS ASSOCIATED WITH ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE COHORT GROUP IN A CROATIAN TERTIARY CENTRE
    Fric, V. Orsic
    Mimica-Matanovic, S.
    Borzan, V.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E114 - E115
  • [30] Inflammatory bowel disease and depressive symptoms: the prevalence and factors associated with depression in patients with inflammatory bowel disease on intravenous biological therapy - single center experience
    Smolovic, B.
    Lukic, M.
    Bojovic, S.
    Vukovic, M. N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (11) : 4008 - 4016
12345